GSK Philippines Recalls Eye Drops With Italian-Made API
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline Philippines has recalled an eye drop product as the Italian manufacturer of the active ingredient failed to comply with Good Manufacturing Practices.